ETFs
K
KNSA
Kiniksa Pharmaceuticals Internat…
78.59
-1.35-1.69%After Hours: 78.54 -0.05 -0.06%19:30 10/16 EDT
OPEN/PREV CLOSE79.32/79.70
TODAY RANGE78.39-81.30
VOL429.71K
MARKET CAP6.30B
52 WEEK RANGE35.20-84.06
AVG VOL (3M)612.97K
% TURNOVER0.42%
TURNOVER--
P/E (TTM)82.20
% RANGE3.63%
EPS(TTM)0.9828
P/E(FORWARD)64.01
P/B9.64
BVPS8.38
DIVIDEND--
P/S9.10
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP3.73B
SHARES OUTSTANDING78.02M
NEXT EARNINGS10/26-10/30
FREE FLOAT46.15M
LOT SIZE1
EX-DATE--
News
Press Releases
Financial Reports
Profile
TipRanks·4h ago
Kiniksa Pharmaceuticals Elevates Ross Moat to President
Simply Wall St·5d ago
What Kiniksa Holders Bought Into Before A 87% Run
TipRanks·10/15 11:57
Citi Sticks to Their Buy Rating for Kiniksa Pharmaceuticals (KNSA)
Seeking Alpha·10/02 09:52
Kiniksa Pharmaceuticals Has Strong Growth And Little Room For Disappointment
TipRanks·09/30 09:40
Analysts’ Top Healthcare Picks: Kiniksa Pharmaceuticals (KNSA), Dexcom (DXCM)
Simply Wall St·09/23 13:44
Is Kiniksa Pharmaceuticals International (KNSA) A Bargain Or Fully Priced On ARCALYST Growth?
NASDAQ·09/17 16:13
Kiniksa Pharmaceuticals Stock Rallies 41% in Three Months: Here's Why
Simply Wall St·09/12 07:24
Kiniksa Pharmaceuticals International (KNSA) Beat Sales Expectations, Is It Still 22% Undervalued?
Simply Wall St·08/09 08:34
Does Raised 2026 Revenue Guidance Change The Bull Case For Kiniksa Pharmaceuticals International (KNSA)?
Simply Wall St·08/01 16:28
Kiniksa Pharmaceuticals International (KNSA) After Raised 2026 Guidance And Strong Q2 Results Looks Fully Valued
TipRanks·08/01 02:02
Insider Shake-Up at Kiniksa Pharmaceuticals Sparks Investor Buzz
Simply Wall St·07/30 20:18
Kiniksa Pharmaceuticals (KNSA) Stock Cools As Raised Guidance Meets ARCALYST Reliance
Dow Jones·07/30 18:53
Kiniksa Pharmaceuticals Is Maintained at Buy by Goldman Sachs
Same Industry
Name/Symbol
Change%
Price